REPLIGEN CORP - COMMON STOCK (RGEN)

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / COMMON STOCK
Shares outstanding
56,095,854
Total 13F shares
56,261,991
Share change
-1,943,393
Total reported value
$10,338,765,280
Put/Call ratio
22%
Price per share
$183.92
Number of holders
480
Value change
-$351,039,614
Number of buys
225
Number of sells
203

Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q1 2024

As of 31 Mar 2024, REPLIGEN CORP - COMMON STOCK (RGEN) was held by 480 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 56,261,991 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, STATE STREET CORP, MACQUARIE GROUP LTD, SANDS CAPITAL MANAGEMENT, LLC, Invesco Ltd., BROWN CAPITAL MANAGEMENT LLC, and Bank of New York Mellon Corp. This page lists 480 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.